Tag: dystrophin

Neurology

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

Newsemia
A joint program of UT Southwestern Medical Center and Children’s Health has been approved as a Certified Duchenne Care Center by Parent Project Muscular Dystrophy,...
Latest News

New drug provides hope for patients with Duchenne muscular dystrophy

Newsemia
The results from three clinical trials have shown that a new drug can successfully delay the progression of Duchenne muscular dystrophy. Source link...
Latest News

New discovery could improve therapies for Duchenne muscular dystrophy

Newsemia
A new multi-institution study spearheaded by researchers at Florida State University and the University of California, Los Angeles suggests a tiny protein could play a...
Latest News

Researchers develop new method to boost efficiency of CRISPR gene editing in DMD

Newsemia
Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have...
Latest News

Single CRISPR treatment can safely and stably correct genetic disease

Newsemia
Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease —...
Neurology

Urine exRNA may be source of biomarkers for muscular dystrophy

Newsemia
Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular...
Biology

Flagship's Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine

Newsemia
WESTMINSTER, Colo. (PRWEB) September 06, 2018 Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be...
Neurology

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Newsemia
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase...
Cardiology

A novel mutation of dystrophin in a Becker muscular dystrophy family with severe cardiac involvement: from genetics to clinicopathology.

Newsemia
Related Articles A novel mutation of dystrophin in a Becker muscular dystrophy family with severe cardiac involvement: from genetics to clinicopathology. Cardiovasc Pathol. 2018 Jul...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World